Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|January 7, 2012
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapyHiroki Yoshioka, Shinji Yamamoto, Hirofumi Hanaoka, et al.
European Journal of Radiology|November 8, 2011
18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological studyKyoichi Kaira, Masato Abe, Kazuo Nakagawa, et al.
Cancer|November 24, 2004
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinomaHiroyuki Kato, Tatsuya Miyazaki, Masanobu Nakajima, et al.
Anticancer Research|December 13, 2005
Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomasHiroyuki Kato, Tatsuya Miyazaki, Masanobu Nakajima, et al.
Pathology Oncology Research : POR|May 31, 2015
Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell CarcinomaOsamu Nikkuni, Kyoichi Kaira, Minoru Toyoda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic studyKyoichi Kaira, Noboru Oriuchi, Yoshimi Otani, et al.
Cancer Science|October 13, 2006
A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinomaJunichi Sakamoto, Noboru Oriuchi, Erito Mochiki, et al.
Endocrine Journal|September 13, 2014
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registryKeiichiro Yoshinaga, Noboru Oriuchi, Hiroshi Wakabayashi, et al.
Journal of Neuro-Oncology|August 2, 2003
Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptorSyuntaro Takasu, Toshitada Takahashi, Sho Okamoto, et al.
BMC Cancer|October 18, 2013
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancerKyoichi Kaira, Yutaka Sunose, Yasuhiro Ohshima, et al.
Pageof 15